Property Information

Bridgeview Technology Park is located in the San Francisco East Bay area, home to a large base of biotechnology and high-tech companies. The property consists of three buildings containing office, laboratory and warehouse space. Two of the buildings were constructed in 1971 and 1977, and renovated in 1998. The third building was constructed in 2002. Primary tenants are Cell Genesys, Inc., a public company focused on the development and commercialization of biological therapies for patients with cancer, which leases space pursuant to two triple-net leases, AstraZeneca PLC, a public company focused on the discovery, development and manufacture of pharmaceuticals for cardiovascular, gastrointestinal, neuroscience, oncology, respiratory, inflammation and infection applications and Intarcia Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of drug therapies utilizing a novel implantable delivery technology.  For information on spaces for lease at the Bridgeview Technology Park, please contact us.